NSF Risk for MRI Patients with Kidney Problems

by Administrator 16. March 2009 02:03

Patients with kidney trouble who have received MRIs as part of diagnosis or treatment for any medical condition should be alert for possible signs of Nephrogenic Systemic Fibrosis, or NSF.

Many FDA-approved MRI contrast agents (chemical solutions used to enhance visibility on MRI scans) contain gadolinium, a heavy metal that has been linked to the development of NSF. In healthy patients, the kidneys are able to filter out the contrast agents' gadolinium content; however, patients whose kidney functions are compromised or reduced in any way may be at risk.

NSF is a serious condition with no definitive treatment. While, initial symptoms typically affect the skin, NSF also attacks vital internal organs, sometimes resulting in death.

If you or someone you love has been diagnosed with NSF following a contrast MRI procedure, contact the NSF lawyers of Williams Kherkher to find out if you have grounds for a legal claim. Call 800-761-3187 today.

Be the first to rate this post

  • Currently 0/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5

Tags:

Nephrogenic Systemic Fibrosis | NSF attorneys | NSF lawyers

Comments

Powered by BlogEngine.NET 1.4.5.0

BlogRoll

Download OPML file OPML

home  |  about the firm  |  attorneys  |  nsf/nsd  |  gadolinium  |  articles  |  contact us  |  blog  |  resources  |  link exchange
© Copyright 2004-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-696-5341

Search Engine Optimization provided by The Search Engine Guys.